CRISPR Therapeutics AG (CRSP.O)

+ 收藏

财务摘要(报告期)(CRISPR Therapeutics AG)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
每股指标:
 每股收益EPS基本(元) -1.94--1.66-0.67-8.36-6.96-4.72-2.32
 每股净资产(元) 23.52-22.8823.5223.8924.9726.8829.01
 每股经营现金净流量(元) -3.25--1.570.11-6.31-4.89-3.56-1.75
 每股现金流量净额(元) 2.21-2.931.67-9.12-5.49-5.49-3.09
 每股营业收入(元) 4.64-2.141.270.020.020.010.01
盈利能力:
 销售毛利率(%) 64.91-48.9257.81-9,102.84-8,576.76-5,780.51-3,160.21
 销售净利率(%) -41.38--76.94-53.07-54,271.70-45,268.46-33,246.90-19,065.64
 净资产收益率平均(%) -8.17--7.09-2.85-30.42-24.79-16.26-7.72
 总资产净利率(%) -6.87--5.89-2.37-26.03-21.14-14.00-6.69
 投入资本回报率ROIC(%) -7.94--6.91-2.70-33.69-29.26-19.24-9.56
收益质量:
 营业利润/利润总额(%) 147.65-124.23124.62103.48102.11101.10100.21
 经营活动产生的现金流量净额/营业收入(%) -70.14--73.208.80-41,380.72-32,081.63-25,245.45-14,387.13
资本结构:
 资产负债率(%) 15.55-17.3417.3516.3916.9715.1213.86
 权益乘数 1.181.001.211.211.201.201.181.16
 产权比率 0.18-0.210.210.200.200.180.16
 流动资产/总资产(%) 85.58-84.6485.0182.6182.1385.5486.74
 非流动资产/总资产(%) 14.42-15.3614.9917.3917.8714.4613.26
 流动负债/负债合计(%) 31.37-34.8737.6932.9537.7732.2031.47
 非流动负债/负债合计(%) 68.63-65.1362.3167.0562.2367.8068.53
 归属母公司股东的权益/投入资本(%) 102.32-103.6497.6392.33105.10106.32116.78
偿债能力:
 流动比率 17.54-14.0013.0015.3012.8117.5719.88
 速动比率 17.54-14.0013.0015.3012.8117.5719.88
 货币资金/流动负债(%) 358.00-334.84234.62174.96327.53414.23601.52
 营业利润/流动负债(%) -204.56--120.23-43.93-555.84-359.00-299.47-154.77
 经营活动产生的现金流量净额/流动负债(%) -239.34--93.685.99-409.34-253.47-231.08-118.95
 归属母公司股东的权益/负债合计(%) 542.96-476.67476.26510.23489.22561.25621.41
 经营活动产生的现金流量净额/负债合计(%) -75.09--32.662.26-134.87-95.75-74.41-37.44
 营业利润/负债合计(%) -64.17--41.92-16.56-183.13-135.61-96.43-48.71
成长能力:
 总资产同比增长率(%) -0.60-100.00-10.81-13.88-18.49-16.60-15.0433.11
 每股净资产同比增长率(%) -1.53-100.00-14.87-18.92-23.35-24.02-21.4721.68
 总负债同比增长率(%) -5.66-100.002.277.814.3029.3425.97137.03
 基本每股收益同比增长率(%) 76.79-64.8371.12-268.21-201.61-155.08-53.64
 归属母公司股东的权益同比增长率(%) 0.39-100.00-13.14-17.37-21.84-22.24-19.7024.34
 营业利润同比增长率(%) 66.94-55.5463.35-280.22-204.31-155.43-53.63
 营业收入同比增长率(%) 30,885.48-15,382.7010,538.30-99.87-99.87-99.8874.40
 股东权益合计同比增长率(%) 0.39-100.00-13.14-17.37-21.84-22.24-19.7024.34
营运能力:
 流动资产周转率次(次) 0.20-0.090.05----
 固定资产周转率次(次) 2.35-1.050.610.010.010.010.01
 总资产周转率次(次) 0.17-0.080.04----
衍生指标:
 现金及现金等价物净增加额TTM(元) 177,009,000.00-56,474,000.00-56,474,000.00-344,688,000.00-715,884,000.00-518,069,000.00-1,151,648,000.00-442,091,000.00
 利润总额TTM(元) -150,722,000.00-423,737,000.00-423,737,000.00-526,636,000.00-650,500,000.00-673,950,000.00-626,574,000.00316,510,000.00
 毛利TTM(元) 240,956,000.0037,590,000.0037,590,000.00-21,538,000.00-109,052,000.00-19,982,000.00-2,856,000.00904,663,000.00
 投入资本(元) 1,840,094,000.00-1,752,218,000.001,899,957,000.002,031,172,000.001,859,205,000.001,966,470,000.001,922,269,000.00
 经营活动产生的现金流量净额TTM(元) -260,375,000.00-342,992,000.00-342,992,000.00-351,703,000.00-495,741,000.00-468,451,000.00-444,562,000.00504,396,000.00
 总营业收入TTM(元) 371,206,000.00170,100,000.00170,100,000.00100,258,000.001,198,000.0014,091,000.0014,821,000.00915,364,000.00
 归属母公司净利润TTM(元) -153,610,000.00-415,929,000.00-415,929,000.00-524,023,000.00-650,175,000.00-680,848,000.00-633,452,000.00311,607,000.00
 所得税TTM(元) 2,888,000.00-7,808,000.00-7,808,000.00-2,613,000.00-325,000.006,898,000.006,878,000.004,903,000.00

前瞻产业研究院